# A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety

> **NCT00229645** · PHASE4 · COMPLETED · sponsor: **Dr Alexander McIntyre Inc.** · enrollment: 60 (—)

## Conditions studied

- Major Depression With Comorbid Anxiety Symptoms

## Interventions

- **DRUG:** Quetiapine Fumarate (Seroquel®)

## Key facts

- **NCT ID:** NCT00229645
- **Lead sponsor:** Dr Alexander McIntyre Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 60 (—)
- **Last updated:** 2016-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00229645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00229645, "A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00229645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*